References
1. Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol. 2010;150 (2):166–70.
2. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, et al. Antim-ullerian Hormone based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009;24:867-75.
3. Gnoth C, Schuring AN, Friol K, Tigges J, Mallmann P, Godehardt E. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod. 2008; 23: 1359-65.
4. Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of Antimullerian hormone in prediction of outcome after IVF : Comparison with the antral follicle count. Fertil Steril. 2009; 91: 705-14.
5. Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Prediction of high ovarian response to controlled ovarian hyperstimulation : Antimullerian hormone versus small antral follicle count (2-6mm) J Assist Reprod Genet. 2009; 26: 319-25.
6. Freour T, Mirallie S, Colombel A, Bach-Ngohou K, Masson D, Barriere P. Anti-mullerian hormone: Clinical relevance in assisted reproductive therapy. Ann Endocrinol. 2006; 67: 567-74.
7. Smeenk JM, Sweep FC, Zielhuis GA, Kremer JA, Thomas CM, Braat DD. Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 2007; 87: 223-226.
8. La Marca A, Stabile G, Artenisio AC, Volpe A. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod 2006; 21 (12): 3103-3107.
9. Visser J. Role of anti-Mullerian hormone in follicle recruitment and maturation. J Gynecol Obstet Biol Reprod (Paris) 2006; 35(5Pt2): 2S30-2S34.
10. Feyereisen E, Mendez Lozano DH, Taieb J, Hesters L, Frydman R, Fanchin R. Anti-Mullerian hormone: clinical insights into a promising biomarker of ovarian follicular status. Reprod Biomed Online 2006; 12(6): 695-703.
11. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. (2004) Serum antimüllerian hormone/ müllerianinhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril.;82(5):1323–9.
12. Eldar-Geva T, Ben-Chetrit A, Spitz IM, Rabinowitz R, Markowitz E, Mimoni T, Gal M, Zylber-Haran E, Margalioth EJ. (2005) Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod.;20(11):3178–83.
13. Wu CH, Chen YC, Wu HH, Yang JG, Chang YJ, Tsai HD. (2009) Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients. J Assist Reprod Genet.; 26(7): 383–9.
14. Broer SL, Mol BW, Hendriks D, Broekmans FJ. (2009) The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril.;91(3): 705–14.
15. Sahmay S, Cetin M, Ocal P, Kaleli S, Senol H, Birol F, Irez T. Serum anti-Müllerian hormone level as a predictor of poor ovarian response in IVF patients. Reprod Med Biol. 2011; 10:9–14.
16. Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I. Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet. 2011;28 (12):1197–203.
17. Ibrahim AA, Maha MB, Hanan HM. Anti-Mullerian and antral follicle count as predictors of ovarian reserve and successful IVF. Asian Pacific J of Reprod 2012; 1(2): 89-92.
18. Wang JG, Douglas NC, Nakhuda GS, Choi JM, Park SJ, Thornton MH, Guarnaccia MM, Sauer MV. The association between anti- Müllerian hormone and IVF pregnancy outcomes is influenced by age. Reprod Biomed Online. 2010 Dec;21(6):757–61.
19. Kini S, Li HW, Morrell D, Pickering S, Thong KJ. Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization. J Assist Reprod Genet. 2010; 27: 449-56.